Macelignan protects against renal ischemia-reperfusion injury via inhibition of inflammation and apoptosis of renal epithelial cells.
Sign Up to like & getrecommendations! Published in 2020 at "Cellular and molecular biology"
DOI: 10.14715/cmb/2019.66.1.9
Abstract: Ischemia-reperfusion injury (IRI) refers to tissue damage that occurs when blood supply returns to tissue after a period of ischemia, anoxia or hypoxia. It occurs frequently during shock, organ transplantation and heart failure. It can cause impairment or even… read more here.
Keywords: macelignan; dose dependently; significantly dose; group ... See more keywords